Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
GLP-1 Receptor Agonist Market Demand, Opportunity, 2026-2034 REPORT DETAILS GLP-1 Receptor Agonist Market Overview The global GLP-1 receptor agonist market size was valued at USD 61.89 billion in 2025
GLP-1R, together with four other glucagon receptors (GCGR, GLP-2R, GIPR, and GHRHR), belongs to the secretin (class B1) GPCR family, whose endogenous ligands are peptide hormones
Underlying Medical Conditions: Conditions such as hypothyroidism, polycystic ovary syndrome (PCOS), and other metabolic disorders can interfere with weight loss
Finally, if you are looking for a prescription and nothing else, you dont need to pay the WeightWatchers membership
However, too much visceral fat can lead to a higher risk of cardiovascular disease
Spending on glucagonlike peptide1 receptor agonists, or GLP1s, in the United States increased over 500% from $13.7 billion in 2018 to $71.7 billion in 2023, according to the Journal of the American Heart Association, Although these medications were initially developed to treat Type 2 diabetes, newer indications now include weight management
US$ 27.42
US$ 25.66
US$ 20.49
